LAURUSLABS.NS Cash Flow
Laurus Labs Ltd.
Profit & Loss Balance Sheet Cash Flow
Cash Flow · 4 years on file
(FY2022-23 to FY2025-26)
· fetched 2026-08-23 23:35
| Line item | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|
| Net Cash from Operating Activities | ₹9.94 Bn | ₹6.66 Bn | ₹6.02 Bn | ₹16.23 Bn | CashFlowsFromUsedInOperatingActivities |
| Net Cash from Investing Activities | ₹-9.96 Bn | ₹-8.22 Bn | ₹-6.82 Bn | ₹-10.89 Bn | CashFlowsFromUsedInInvestingActivities |
| Net Cash from Financing Activities | ₹-0.27 Bn | ₹2.50 Bn | ₹0.39 Bn | ₹-5.25 Bn | CashFlowsFromUsedInFinancingActivities |
| Effect of Exchange Rate Changes | ₹-0.01 Bn | ₹0.00 Bn | ₹0.01 Bn | ₹0.03 Bn | EffectOfExchangeRateChangesOnCashAndCashEquivalents |
| Net Increase/(Decrease) in Cash | ₹-0.30 Bn | ₹0.93 Bn | ₹-0.39 Bn | ₹0.13 Bn | IncreaseDecreaseInCashAndCashEquivalents |
| Cash and Cash Equivalents (Closing) | ₹0.75 Bn | ₹0.46 Bn | N/A | N/A | CashAndCashEquivalentsCashFlowStatement |
Every figure above is the exact value of the named XBRL element from LAURUSLABS.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).